"Navigating the Modern News Zoo so you don't have to."
Wednesday, July 16, 2025
Diabetes patients on Ozempic-like drugs more likely to develop gastroesophageal reflux disease
A population-based cohort study emulating a target trial estimated the effect of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared with sodium-glucose cotransporter-2 (SGLT-2) inhibitors on the risk for gastroesophageal reflux disease (GERD) and its complications in patients with type 2 diabetes.
đ Full Story
I Tried the Almost Perfect Fold! *Vivo Xfold 5*
- 'Just the beginning': New UNO-themed games, social clubs coming to casinos across US
- Boat Migrants Arenât the Real Problem â So Why Is Britain Panicking? Fatima Drops a Shocking Bombshell on Live TV - Isaiah Amos
- Mamdani: I'll Shut Up About Globalizing the Intifada. For Now.
- Anthropic launches finance-specific Claude with built-in data connectors, higher limits and prompt libraries - Emilia David
- The Fusion of Anti-Zionism and Social Justice - Mark Pinkert and Susan Greene
- Is Beef Tallow the Next Big Thing in Skincare? - Kirstyn Hill, PharmD, MPH
Elon And Trump Break Up - What Happens Now
- TikTok and Ticketmaster Unite to Revolutionize Music Industry in 20+ Countries - Bertha Stephens
- Pig Pursuit: Curly-tailed fugitives nabbed after making off with a shoe, biting deputy
- What It Means To Be HypersexualâPlus, Tips for Managing It - Wendy Wisner
- The Iran Cyber Threat Is Real - MeighTimbol
- Waiting for 0% Interest Rates? Donât Hold Your Breath
- The Implications of ChatGPT's Upcoming Video-Creation Capabilities - Michael Terry
